Bz-L-His-OMe

Bz-L-His-OMe is an L-histidine methyl ester bearing a benzyl (Bz) protecting group on the imidazole-containing amino acid framework. The structure combines a stereochemically defined alpha-amino acid center with a protected carboxylate (methyl ester) and a benzyl-protected side-chain functionality that modulates nucleophilicity and peptide-coupling behavior. The imidazole ring remains present as a key heteroaromatic site for acid-base chemistry and coordination, while the ester and benzyl protection enable controlled transformations during protected amino acid synthesis. The compound's reactivity profile supports stepwise derivatization, including conversion to peptide-ready intermediates and downstream functionalization of the histidine side chain under conditions compatible with chiral amino acid handling.

1. Peptide Synthesis

Bz-L-His-OMe supports peptide building block preparation where the L-histidine stereocenter and protected functional groups help manage chemoselective coupling. The methyl ester can be used as a protected carboxyl handle for controlled activation strategies, while the benzyl protection helps suppress undesired side reactions during amide bond formation. The imidazole side chain can be carried through coupling steps and later adjusted via deprotection or derivatization to tune metal-binding and hydrogen-bonding properties in the resulting peptide. Peptide chemists can employ Bz-L-His-OMe to construct histidine-containing sequences and to generate peptide analogs suitable for biochemical binding studies and structural probes.

2. Side-Chain Functionalization

Bz-L-His-OMe is suitable for chemical biology and synthetic organic chemistry workflows that require histidine side-chain reactivity control. The imidazole moiety enables metal coordination and pH-dependent behavior, while the protected benzyl and ester functionalities allow selective transformations without immediate interference from free carboxylate or strongly nucleophilic sites. Derivatization routes can be designed to introduce functional handles on the imidazole or to convert the ester into alternative electrophiles for subsequent conjugation chemistry. Downstream histidine-modified derivatives can serve as intermediates for peptidomimetics, coordination complexes, and structure-activity relationship (SAR) libraries where side-chain chemistry drives molecular recognition.

3. Chiral Amino Acid Intermediate

Bz-L-His-OMe functions as a chiral amino acid intermediate for stereochemically defined synthesis of protected histidine derivatives. The L-configuration at the alpha-carbon provides stereochemical fidelity for downstream peptide coupling and for generating enantiopure intermediates used in fragment assembly. The methyl ester and benzyl protection strategy supports sequential deprotection and functional-group interconversion, enabling controlled access to carboxylic acid forms, activated derivatives, or alternative protected states required for peptide coupling chemistry. Industrial and research settings can apply Bz-L-His-OMe in process chemistry intermediate preparation where chiral consistency and functional-group compatibility are central to reliable manufacturing of amino acid building blocks.

4. Bioconjugation Chemistry

Bz-L-His-OMe can be applied to bioconjugation and biomolecule modification strategies that rely on histidine's imidazole chemistry for selective attachment or coordination-based interactions. The protected ester and benzyl group help maintain stability during reagent handling, while the imidazole ring provides a site for controlled derivatization into conjugation-ready motifs. Conversion of the carboxyl functionality and subsequent side-chain modification can enable attachment of histidine-containing linkers to proteins, peptides, or polymer backbones while preserving defined stereochemistry. Bioconjugation workflows can use Bz-L-His-OMe-derived intermediates to build molecular constructs for analytical labeling, affinity reagents, and coordination-assisted immobilization formats.

5. Pharmaceutical Intermediate Preparation

Bz-L-His-OMe is relevant to pharmaceutical manufacturing and fine chemical synthesis where protected amino acid derivatives serve as controlled inputs for larger synthetic sequences. The combination of an L-amino acid stereocenter with an imidazole-containing side chain supports incorporation into peptide-like scaffolds and peptidomimetic fragments used in medicinal chemistry programs. The benzyl protection and methyl ester form can be leveraged to design stepwise protection/deprotection logic that aligns with industrial process constraints, such as chemoselectivity during activation and coupling steps. Downstream conversion into acid or activated intermediates enables integration into controlled manufacturing routes for histidine-containing intermediates and specialty chemical production.

1. Spatiotemporal delivery of nanoformulated liraglutide for cardiac regeneration after myocardial infarction

2. Myotropic activity and immunolocalization of selected neuropeptides of the burying beetle Nicrophorus vespilloides (Coleoptera: Silphidae)

3. Immune responses to homocitrulline-and citrulline-containing peptides in rheumatoid arthritis

4. Immune responses to peptides containing homocitrulline or citrulline in the DR4-transgenic mouse model of rheumatoid arthritis

5. Sex differences in oxidative stress level and antioxidative enzymes expression and activity in obese pre-diabetic elderly rats treated with metformin or liraglutide